Skip to content

Drug interactions

Montelukast + Sparsentan

Severity: Minor

Montelukast and Sparsentan: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Sparsentan induces CYP3A4 and may modestly lower exposure to drugs cleared by this route, including partly montelukast. Because the main pathway for montelukast is CYP2C8 and the effect is expected to be small, clinical significance is limited.

What this interaction means in plain words

Montelukast and Sparsentan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Montelukast belongs to Respiratory; Sparsentan belongs to Genitourinary.

Evidence level: Low

Why it happens

Sparsentan is a weak inducer of CYP3A4 and possibly CYP2C enzymes, increasing montelukast clearance.

What to do

No dose change is routinely required; watch for loss of asthma or allergy control.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Montelukast and Sparsentan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Montelukast with Sparsentan?

MediHelp rates the interaction as minor. Montelukast and Sparsentan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Sparsentan induces CYP3A4 and may modestly lower exposure to drugs cleared by this route, including partly montelukast. Because the main pathway for montelukast is CYP2C8 and the effect is expected to be small, clinical significance is limited.

How serious is the interaction between Montelukast and Sparsentan?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is routinely required; watch for loss of asthma or allergy control.

What other medicines interact with Montelukast?

MediHelp also lists interactions of Montelukast with, for example, Apalutamide, Carbamazepine, Deferasirox. The full list is on the Montelukast page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in